Several natural and synthetic coumarins were assayed against different cancer cell lines. Four of them have shown cytotoxicity against a panel of three human solid tumor cell lines (HeLa, T-47D, and WiDr) and a clearly activity/hydrophobicity relationship. Compound 13 proved to be the most active product in all cell lines tested, with values of 8.0 (±0.38) μM against HeLa cells and also able to inhibit Taq DNA polymerase. This dual activity of 13 makes it a candidate to be considered as a “lead” compound in the search for novel antitumor drugs.
ThakurA, SinglaR, JaitakV. (2015) Coumarins as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies. European Journal of Medicinal Chemistry, 101, 476–495.
2.
TraykovaM, KostovaI. (2005) Coumarin derivatives and oxidative stress. International Journal of Pharmacology, 1, 29–32.
3.
ChimichiS, BoccaliniM, CosimelliB, ViolaG, VedaldiD, Dall'AcquaF. (2002) New geiparvarin analogues from 7-(2-oxoethoxy)coumarins as efficient in vitro antitumoral agents. Tetrahedron Letters, 43, 7473–7476.
4.
De SouzaE, SallesD, MaistroaE. (2015) Assessment of the genotoxic/clastogenic potential of coumarin derivative 6,7-dihydroxycoumarin (asculetin) in multiple mouse organs. Toxicology Reports, 2, 268–274.
5.
KostovaI, ManolovI, MomekovG. (2004) Cytotoxic activity of new neodymium (III) complexes of bis-coumarins. European Journal of Medicinal Chemistry, 39, 765–775.
6.
JacquotY, LaıosI, CleerenA, NonclercqD, BermontL, RefouveletB, BoubekeurK, XiclunaA, LeclercqG, LaurentG. (2007) Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells. Bioorganic & Medicinal Chemistry, 15, 2269–2282.
7.
WijkmansC, BeckettR. (2002) Combinatorial chemistry in anti-infectives research. Drug Discovery Today, 7, 126–132.
8.
GarroH, GarcíaC., MartínV., TonnC, PungitoreC. (2014) Chemistry and biological activity of coumarins at molecular level. Natural Product Communications, 9, 1091–1094.
9.
GarroH, ManzurM, CiuffoG, TonnC, PungitoreC. (2014) Inhibition of reverse transcriptase and Taq DNA polymerase by compounds possessing the coumarin framework. Bioorganic and Medicinal Chemistry Letters, 24, 760–64.
10.
SkehanP, StorengP, ScudeiroD, MonksA, McMahonJ, VisticaD, WarrenJ, BokeschH, KenneyS, BoydM. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute, 82, 1107–1112.
11.
MonksA, ScudieroD, SkehanP, ShoemakerR, PaullK, VisticaD, HoseC, LangleyJ, CroniseP, Vaigro-WolffA, Gray-GoodrichM, CampbellH, MayoJ, BoydM. (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. Journal of the National Cancer Institute, 83, 757–766.
12.
RetaG, TonnC, Ríos-LuciC, LeónL, Pérez-RothE, PadrónJ, DonadelO. (2012) Cytotoxic bioactivity of some phenylpropanoic acid derivatives. Natural Product Communications, 7, 1341–1346.
DonadelO, VillarJ, MartinT, PadronJ. (2005) The tert-butyl dimethyl silyl group as an enhancer of drug cytotoxicity against human tumor cells. Bioorganic & Medicinal Chemistry Letters, 15, 3536–3539.
15.
Van HattumA, PinedoH, SchluperH, HausheerF, BovenE. (2000) New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer. International Journal of Cancer, 88, 260–266.
16.
BenceA, MattinglyC, BurkeT, AdamsV. (2004) The effect of DB-67, a lipophilic camptothecin derivative, on topoisomerase I levels in non-small-cell lung cancer cells. Cancer Chemotherapy Pharmacology, 54, 354–360.
17.
AndersonW, KasliwalR, HoustonD, WangY, NarayananV, HaugwitzR, PlowmanJ. (1995) Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum(II) and platinum(IV) complexes derived from beta-silyl amines. Journal of Medicinal Chemistry, 38, 3789–3797.
18.
GarroH, PungitoreC. (2015) Coumarins as potential inhibitors of DNA polymerases and reverse transcriptases. Searching new antiretroviral and antitumoral drugs. Current Drug Discovery Technologies, 12, 66–79.
19.
PungitoreC, LeonL, GarcíaC., MartínV., TonnC, PadrónJ. (2007) Novel antiproliferative analogs of the Taq DNA polymerase inhibitor catalpol. Bioorganic & Medicinal Chemistry Letters, 17, 1332–1335.
